ANI Pharmaceuticals, Inc.
ANI Pharmaceuticals, Inc. (ANIP) Stock Overview
Explore ANI Pharmaceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
1.7B
P/E Ratio
40.91
EPS (TTM)
$1.60
ROE
0.08%
ANIP Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of ANI Pharmaceuticals, Inc. (ANIP) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 42.43, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $92.87.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 40.91 and a market capitalization of 1.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.